Oct 9 (Reuters) - Genoptix Inc, which provides diagnostic services to hematologists and oncologists, on Tuesday registered its initial public offering of 5 million shares for an estimated price of $14 to $16 per share.
Oct 9 (Reuters) - Genoptix Inc, which provides diagnostic services to hematologists and oncologists, on Tuesday registered its initial public offering of 5 million shares for an estimated price of $14 to $16 per share.